A Pharmacokinetic Study of TS-172 in Patients With Hepatic Impairment

NCT07231029 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Patients With Mild or Moderate Hepatic Impairment

Interventions

DRUG: TS-172

Sponsor

Taisho Pharmaceutical Co., Ltd.